More americans living longer with cardiovascular disease will increase costs while lowering quality of life

Health Affairs

Volumn 32, Issue 10, 2013, Pages 1706-1714

  Pandya, Ankur ^a   Gaziano, Thomas A ^b   Weinstein, Milton C ^c   Cutler, David ^d  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; AGING; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH SURVEY; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OBESITY; PHYSICAL ACTIVITY; PREVALENCE; QUALITY OF LIFE; RISK FACTOR; SMOKING; SYSTOLIC BLOOD PRESSURE; UNITED STATES; WESTERN HEMISPHERE; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDY; ECONOMICS; LIFE EXPECTANCY; MIDDLE AGED; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH SURVEYS; HUMANS; LIFE EXPECTANCY; MALE; MIDDLE AGED; QUALITY OF LIFE; UNITED STATES;

EID: 84885408706     PISSN: 02782715     EISSN: 15445208     Source Type: Journal    
DOI: 10.1377/hlthaff.2013.0449     Document Type: Article

References (45)

1. National Center for Health Statistics. National Vital Statistics System data. Hyattsville (MD): NCHS; 2012.
2. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, et al. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation. 2012;125(1):e2-220.
3. Feinleib M, Kannel WB, Garrison RJ, McNamara PM, Castelli WP. The Framingham Offspring Study. Design and preliminary data. Prev Med. 1975;4(4):518-25.
4. White AD, Folsom AR, Chambless LE, Sharret AR, Yang K, Conwill D, et al. Community surveillance of coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) Study: methods and initial two years' experience. J Clin Epidemiol. 1996;49(2): 223-33.
5. National Center for Health Statistics. National Health and Nutrition Examination Survey data. Hyattsville (MD): NCHS; 2012.
6. Rosamond WD, Chambless LE, Folsom AR, Cooper LS, Conwill DE, Clegg L, et al. Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994. N Engl J Med. 1998;339(13):861-7.
7. Pearson TA. The prevention of cardiovascular disease: have we really made progress?. Health Aff (Millwood). 2007;26(1):49-60.
8. Gregg EW, Cheng YJ, Cadwell BL, Imperatore G, Williams DE, Flegal KM, et al. Secular trends in cardiovascular disease risk factors according to body mass index in US adults. JAMA. 2005;293(15):1868-74.
9. Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet. 2005;366(9493):1267-78.
10. Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009;338:b1665.
11. Stewart ST, Cutler DM, Rosen AB. Forecasting the effects of obesity and smoking on U.S. life expectancy. N Engl J Med. 2009;361(23):2252-60.
12. Silverstein MD, Nietert PJ, Zoller JS, Silvestri GA. Predicted impact of attaining smoking reduction goals on mortality. South Med J. 2001;94(2): 176-83.
13. Olshansky SJ, Passaro DJ, Hershow RC, Layden J, Carnes BA, Brody J, et al. A potential decline in life expectancy in the United States in the 21st century. N Engl J Med. 2005;352(11):1138-45.
14. Huffman MD, Capewell S, Ning H, Shay CM, Ford ES, Lloyd-Jones DM. Cardiovascular health behavior and health factor changes (1988-2008) and projections to 2020: results from the National Health and Nutrition Examination Surveys. Circulation. 2012;125(21): 2595-602.
15. Kahn R, Robertson RM, Smith R, Eddy D. The impact of prevention on reducing the burden of cardiovascular disease. Circulation. 2008; 118(5):576-85.
16. Capewell S, Ford ES, Croft JB, Critchley JA, Greenlund KJ, Labarthe DR. Cardiovascular risk factor trends and potential for reducing coronary heart disease mortality in the United States of America. Bull World Health Organ. 2010;88(2):120-30.
17. Bibbins-Domingo K, Coxson P, Pletcher MJ, Lightwood J, Goldman L. Adolescent overweight and future adult coronary heart disease. N Engl J Med. 2007;357(23):2371-9.
18. Jones DS, Greene JA. The contributions of prevention and treatment to the decline in cardiovascular mortality: lessons from a forty-year debate. Health Aff (Millwood). 2012; 31(10):2250-8.
19. D'Agostino RB Sr., Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008;117(6): 743-53.
20. Wierzbicki AS, Mikhailidis DP. Beyond LDL-C-the importance of raising HDL-C. Curr Med Res Opin. 2002;18(1):36-44.
21. Yang Q, Cogswell ME, Flanders WD, Hong Y, Zhang Z, Loustalot F, et al. Trends in cardiovascular health metrics and associations with allcause and CVD mortality among US adults. JAMA. 2012;307(12): 1273-83.
22. To access the Appendix, click on the Appendix link in the box to the right of the article online.
23. HealthyPeople.gov. 2020 topics and objectives: nutrition and weight status [Internet]. Washington (DC): Department of Health and Human Services; [last updated 2013 Aug 28; cited 2012 Sep 12]. Available from: http://www.healthypeople.gov/2020/topicsobjectives2020/objectiveslist.aspx?topicId=29
24. Wang YC, Colditz GA, Kuntz KM. Forecasting the obesity epidemic in the aging U.S. population. Obesity. 2007;15(11):2855-65.
25. Heidenreich PA, Trogdon JG, Khavjou OA, Butler J, Dracup K, Ezekowitz MD, et al. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation. 2011; 123(8):933-44.
26. Harper S, Lynch J, Smith GD. Social determinants and the decline of cardiovascular diseases: understanding the links. Annu Rev Public Health. 2011;32:39-69.
27. Dray-Spira R, Gary TL, Brancati FL. Socioeconomic position and cardiovascular disease in adults with and without diabetes: United States trends, 1997-2005. J Gen Intern Med. 2008;23(10):1634-41.
28. National Cholesterol Education Program (NCEP) Expert Panel on Detection Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106(25): 3143-421.
29. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr., et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003; 289(19):2560-72.
30. Gaziano JM, Gaziano TA. Simplifying the approach to the management of dyslipidemia. JAMA. 2009;302(19):2148-9.
31. Kuklina EV, Yoon PW, Keenan NL. Trends in high levels of low-density lipoprotein cholesterol in the United States, 1999-2006. JAMA. 2009; 302(19):2104-10.
32. Slattery ML, Murtaugh MA, Quesenberry C, Caan BJ, Edwards S, Sweeney C. Changing population characteristics, effect-measure modification, and cancer risk factor identification. Epidemiol Perspect Innov. 2007;4:10.
33. Frieden TR, Berwick DM. The "Million Hearts" initiative-preventing heart attacks and strokes. N Engl J Med. 2011;365(13):e27.
34. Regressions that predicted saturated fat consumption, diabetes, cholesterol treatment, total cholesterol, and blood pressure treatment(women only) required calibrated regression intercepts (so that the predicted levels for these averages in 2010 match observed trends). Appendix Tables A-7 and A-8 (see Note 22) show that results were robust to the following changes in modeling assumptions: performing projections without calibration adjustments; limiting regressions to recent data (2000-10); and using relative risks for cholesterol and blood pressure treatments instead of improvement in clinical values.
35. Ford ES, Ajani UA, Croft JB, Critchley JA, Labarthe DR, Kottke TE, et al. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med. 2007; 356(23):2388-98.
36. Foot DK, Lewis RP, Pearson TA, Beller GA. Demographics and cardiology, 1950-2050. J Am Coll Cardiol. 2000;35(4):1067-81.
37. Green LV, Savin S, Lu Y. Primary care physician shortages could be eliminated through use of teams, nonphysicians, and electronic communication. Health Aff (Millwood). 2013;32(1):11-9.
38. Aneja S, Ross JS, Wang Y, Matsumoto M, Rodgers GP, Bernheim SM, et al. US cardiologist workforce from 1995 to 2007: modest growth, lasting geographic maldistribution especially in rural areas. Health Aff (Millwood). 2011;30(12): 2301-9.
39. Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA. 2012;307(5):491-7.
40. Olds T, Maher C, Zumin S, Péneau S, Lioret S, Castetbon K, et al. Evidence that the prevalence of childhood overweight is plateauing: data from nine countries. Int J Pediatr Obes. 2011;6(5-6):342-60.
41. Pletcher MJ, Lazar L, Bibbins-Domingo K, Moran A, Rodondi N, Coxson P, et al. Comparing impact and cost-effectiveness of primary prevention strategies for lipidlowering. Ann Intern Med. 2009; 150(4):243-54.
42. Lazar LD, Pletcher MJ, Coxson PG, Bibbins-Domingo K, Goldman L. Cost-effectiveness of statin therapy for primary prevention in a low-cost statin era. Circulation. 2011;124(2): 146-53.
43. Thorpe KE. The rise in health care spending and what to do about it. Health Aff (Millwood). 2005;24(6): 1436-45.
44. Mazzaglia G, Ambrosioni E, Alacqua M, Filippi A, Sessa E, Immordino V, et al. Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients. Circulation. 2009;120(16):1598-605.
45. Dragomir A, Côté R, White M, Lalonde L, Blais L, Bérard A, et al. Relationship between adherence level to statins, clinical issues and health-care costs in real-life clinical setting. Value Health. 2010;13(1): 87-94.